Behavioral effects and ChE measures after acute and repeated administration of malathion in rats

Environmental Toxicology and Pharmacology

Volumn 20, Issue 3, 2005, Pages 443-449

  Assini, Fabrício L ^a   Zanette, Kênia D ^a   Brocardo, Patrícia S ^a   Pandolfo, Pablo ^a   Rodrigues, Ana Lúcia S ^a   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Depression; Malathion; Organophosphorus

Indexed keywords

ACETYLCHOLINESTERASE; MALATHION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; LONG TERM EXPOSURE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TEMPERATURE DEPENDENCE;

ANIMALIA;

EID: 24944464165     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2005.05.007     Document Type: Article

References (49)

1. V. Baillea, F. Dorandeua, P. Carpentiera, J.C. Bizotb, P. Filliata, E. Foura, J. Denisc, and G. Lallementa Acute exposure to a low or mild dose of soman: Biochemical, behavioral and histopathological effects Pharmacol. Biochem. Behav. 69 2001 561
2. M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248
3. L. Brenner Malathion J. Pesticide Reform. 12 1992 29
4. J.D. Brioni, A.B. O'Neill, J. Kim, M.J. Buckley, M.W. Decker, and S.P. Arneric Anxiolytic-like effects of the novel cholinergic channel activator ABT-418 J. Pharmacol. Exp. Ther. 271 1994 353
5. P.S. Brocardo, P. Pandolfo, R.N. Takahashi, A.L.S. Rodrigues, and A.L. Dafre Antioxidant defenses and lipid peroxidation in the cerebral cortex and hippocampus following acute exposure to malathion and/or zinc chloride Toxicology 207 2005 283
6. R.L. Carr, H.W. Chambers, J.A. Guarisco, J.R. Richardson, J. Tang, and J.E. Chambers Effects of repeated oral postnatal exposure to chlorpyrifos on open-field behavior in juvenile rats Toxicol. Sci. 59 2001 260
7. J. Cocker, H.J. Mason, and K.J. Garfitt Biological monitoring of exposure to organophosphate pesticides Toxicol. Lett. 134 2002 97
8. C. Colosio, M. Tiramani, and M. Maroni Neurobehavioral effects of pesticides: state of the art Neurotoxicology 24 2003 577
9. G.R. Dawson, and M.D. Tricklebank Use of the elevated plus-maze in the search for novel anxiolytic agents Trends Pharmacol. Sci. 16 1995 33
10. H. Einat, R.H. Belmaker, A. Zangen, D.H. Overstreet, and G. Yadid Chronic inositol treatment reduces depression-like immobility of Flinders sensitive line rats in the forced swim test Depress. Anxiety 15 2002 148
11. G.L. Ellman, K.O. Courtney, V. Andres, and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88
12. J. Fritze The adrenergic-cholinergic imbalance hypothesis of depression: a review and a perspective Rev. Neurosci. 41 1993 63
13. S.E. File, L.E. Gonzalez, and N. Andrews Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors Behav. Neurosci. 112 1998 352
14. M. Garcia-Alloza, F.J. Gil-Bea, M. Diez-Ariza, C.P. Chen, P.T. Francis, B. Lasheras, and M.J. Ramirez Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia 43 2005 442
15. C.J. Gordon Thermoregulation in laboratory mammals and humans exposed to anticholinesterase agents Neurotoxicol. Teratol. 16 1994 427
16. R.C. Gupta Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants Neurotoxicology 22 2001 271
17. A. Hazarika, S.N. Sarkar, S. Hajare, M. Kataria, and J.K. Malik Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study Toxicology 185 2003 1
18. C.S. Lal, V. Kumar, A. Ranjan, V.N. Das, N. Kumar, K. Kishore, and S.K. Bhattacharya Evaluation of cholinesterase level in an endemic population exposed to malathion suspension formulation as a vector control measure Mem. Inst. Oswaldo Cruz 99 2004 219
19. P. Lee, and D.Y. Tai Clinical features of patients with acute organophosphate poisoning requiring intensive care Intens. Care Med. 27 2001 694
20. R.G. Lister Ethologically-based animal models of anxiety disorders Pharmacol. Ther. 46 1990 321
21. M. Makino, Y. Kitano, C. Komiyama, M. Hirohashi, and K. Takasuna Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test Br. J. Pharmacol. 130 2000 1269
22. K.L. McDaniel, and V.C. Moser Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin Neurotoxicol. Teratol. 15 1993 71
23. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13
24. A.C. Nostrandt, S. Padilla, and V.C. Moser The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat Pharmacol. Biochem. Behav. 58 1997 15
25. P. Olausson, J.A. Engel, and B. Soderpalm Behavioral sensitization to nicotine is associated with behavioral disinhibition, counteraction by citalopram Psychopharmacology 142 1999 111
26. A.M. Ouagazzal, P.J. Kenny, and S.E. File Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine Psychopharmacology 144 1999 54
27. T. Parron, A.F. Hernandez, and E. Villanueva Increased risk of suicide with exposure to pesticides in an intensive agricultural area. A 12-year retrospective study Forensic. Sci. Int. 79 1996 53
28. S. Pellow, and S.E. File Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat Pharmacol. Biochem. Behav. 24 1986 525
29. R. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatment Nature 266 1977 730
30. J. Prathiba, K.B. Kumar, and K.S. Karanth Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behavior in clomipramine model of depression Brain Res. 867 2000 243
31. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur. J. Pharmacol. 463 2003 3
32. T.J. Reidy, R.M. Bowler, S.S. Rauch, and G.I. Pedroza Pesticide exposure and neuropsychological impairment in migrant farm workers Arch. Clin. Neuropsychol. 7 1992 85
33. R.J. Rodgers, and J. Cole Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety Behav. Pharmacol. 6 1995 283
34. P.J. Rowsey, and C.J. Gordon Tolerance to the hypothermic and hyperthermic effects of chlorpyrifos Toxicology 121 1997 215
35. R.J. Salín-Pascual, M. Rosas, A. Jimenez-Genchi, B.L. Rivera-Meza, and V. Delgado-Parra Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression J. Clin. Psychiatry 57 1996 387
36. R.S. Salvi, D.R. Lara, E.S. Ghisol, L.V. Portela, R.D. Dias, and D.O. Souza Neuropsychiatric evaluation in subjects chronically exposed to organophosphate Pest. Toxicol. Sci. 72 2003 267
37. M.C. Sanchez-Amate, P. Flores, and F. Sanchez-Santed Effects of chlorpyrifos in the plus-maze model of anxiety Behav. Pharmacol. 12 2001 285
38. E.P. Savage, T.J. Keffe, M.L. Mounce, R.K. Heaton, J.A. Lewis, and P.J. Burcar Chronic neurologic sequelae of acute organophosphate pesticide poisoning Arch. Environ. Health 43 1988 38
39. J.W. Smythe, D. Murphy, S. Bhatnagar, C. Timothy, and B. Costall Muscarinic antagonists are anxiogenic in rats tested in the black-white box Pharmacol. Biochem. Behav. 54 1996 57
40. L. Stallones, and C. Beseler Pesticide poisoning and depressive symptoms among farm residents Ann. Epidemiol. 12 2002 389
41. M.I. Sweeney, and M.E. Lyon Selective effect of malathion on blood coagulation versus locomotor activity J. Environ. Pathol. Toxicol. Oncol. 18 1999 203
42. R.N. Takahashi, A. Poli, G.S. Morato, T.C. Lima, and M. Zanin Behavioral and biochemical changes following repeated administration of carbaryl to aging rats Braz. J. Med. Biol. Res. 23 1990 879
43. R.N. Takahashi, A. Poli, G.S. Morato, T.C. Lima, and M. Zanin Effects of age on behavioral and physiological responses to carbaryl in rats Neurotoxicol. Teratol. 13 1991 21
44. Y. Tizabi, D.H. Overstreet, A.H. Rezvani, V.A. Louis, E. Clark Jr., D.S. Janowsky, and M.A. Kling Antidepressant effects of nicotine in an animal model of depression Psychopharmacology 142 1999 193
45. G. Vázquez-Palacios, H. Bonilla-Jaime, and J. Velázquez- Moctezuma Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine Pharmacol. Biochem. Behav. 78 2004 165
46. G. Vàzquez-Palacios, H. Bonilla-Jaime, and J. Velazquez-Moctezuma Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 39
47. T.R. Ward, and W.R. Mundy Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex Brain Res. Bull. 39 1996 49
48. P. Willner Animal models of depression: an overview Pharmacol. Ther. 45 1990 425
49. L. Zhang, F.M. Zhou, and J.A. Dani Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release Mol. Pharmacol. 66 2004 538